INDBInternet News Database 2.5 Updated 1 min ago · 393 sources Show or hide images Light or dark

Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

Save Like Comments Compare coverage
Image from Amherst Bee

Summary

Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners. Covered by 4 outlets: 4 are not rated.

Automated summary picked from the outlets' own descriptions.

Who is covering this

  1. Coronado Eagle & Journal Not rated US
    Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

    Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners.

  2. KVOA Not rated US
    Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

    Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners.

  3. The Dispatch Not rated US
    Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

    Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners.

  4. Houston Forward Times Not rated US
    Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

    Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners.

  5. Amherst Bee Not rated US
    Frost & Sullivan and Medtide Inc. Release White Paper on the Global Peptide and Oligonucleotide Drug Industry

    Growing use of GLP-1 therapies and advances in oligonucleotide delivery are changing what drugmakers need from their manufacturing partners.

Comments

Comments need JavaScript.